The select study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Neal, J. W.; Pennell, N. A.; Govindan, R.; Heist, R. S.; Shaw, A. T.; Muzikansky, A.; Jänne, P. A.; Lynch, T. J.; Azzoli, C. G.; Sequist, L. V.
Abstract Title: The select study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
Meeting Title: 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology
Journal Title: Journal of Thoracic Oncology
Volume: 7
Issue: 9 Suppl. 4
Meeting Dates: 2012 Sep 6-8
Meeting Location: Chicago, IL
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2012-09-01
Start Page: S209
Language: English
ACCESSION: WOS:000317035000018
PROVIDER: wos
Notes: --- - Meeting Abstract: 16 - "4" - "Source: Wos"
MSK Authors
  1. Christopher G Azzoli
    111 Azzoli